Amiel Dror

Amiel received his B.Sc. degree at the Faculty of Agriculture, Food and Environment of the Hebrew University, Rehovot, Israel. In parallel to his bachelor’s studies, he worked as a laboratory assistant in the Department of Plant Sciences at the Weizmann Institute of Science, where he was exposed to the world of transposable elements and homologous recombination. He then decided to pursue his studies in the field of human genetics. Dr. Dror received his M.D. and Ph.D degrees from the Sackler School of Medicine at Tel Aviv University, Tel Aviv, Israel. His Ph.D., obtained in 2012, focused on studying the mechanisms that underlie deafness as a result of SLC26A4 mutations. Human mutations in SLC26A4 lead to a non-syndromic (DFNB4) and syndromic form of deafness with enlargement of the thyroid gland (Pendred syndrome). In particular, he studied an ENU-generated mouse model, loop, with a mutation in the Slc26a4 gene. Dr. Dror is currently an otolaryngologist resident-scientist at the Department of Otorhinolaryngology Head and Neck Surgery at the Galilee Medical Center (GMC) affiliated to the Bar-Ilan University, Azrieli Faculty of Medicine in northern Israel.